Nova Law Review
Volume 43, Issue 2

2019

Article 4

CRISPR Has the Potential to Change the
World, but First We Have to Give It a Chance
Sarah J. Schultz∗

∗

Nova Southeastern University Shepard Broad College of Law, ss2739@mynsu.nova.edu

Copyright c 2019 by the authors. Nova Law Review is produced by The Berkeley Electronic
Press (bepress). https://nsuworks.nova.edu/nlr

Schultz: CRISPR Has the Potential to Change the World, but First We Have t

CRISPR HAS THE POTENTIAL TO CHANGE THE WORLD,
BUT FIRST WE HAVE TO GIVE IT A CHANCE
SARAH J. SCHULTZ *
I.
II.

III.

IV.

INTRODUCTION............................................................................... 178
HOW DOES CRISPR WORK? ......................................................... 180
A.
Explanation of Genome Editing........................................ 180
B.
How is CRISPR Technology Different?............................ 181
C.
Benefits of CRISPR ........................................................... 183
1.
Elimination of Genetic Diseases.......................... 183
2.
Cutting Down on Health Care Expenses ............. 184
3.
High Rate of Precision and Accuracy.................. 185
4.
Forget the Shortage of Organ Donors.................. 186
D.
Legitimate Concerns ......................................................... 187
1.
Freewheeling Biohackers..................................... 187
2.
Designer Babies ................................................... 188
3.
What Constitutes a Genetic Problem That Needs
Fixing? ................................................................. 189
THE CURRENT FDA BAN ON CRISPR HUMAN TRIALS IN THE
UNITED STATES.............................................................................. 190
A.
Has CRISPR Been Tested in Other Countries? ................ 191
B.
Why the FDA Should Allow Human Trials in the United
States................................................................................. 192
1.
Many of Those with Genetic Diseases Are Out of
Options................................................................. 193
2.
But What About These Products?........................ 194
a.
Big Tobacco ............................................ 194
b.
Even the Widely Used Chemotherapy..... 197
C.
Is This Big Pharma at Play?............................................. 198
CONCLUSION .................................................................................. 201

*
Sarah J. Schultz earned her bachelor’s degree in Biomedical Sciences at
the University of South Florida. She earned her J.D. degree May 2019 at Nova Southeastern
University, Shepard Broad College of Law. Sarah would first like to thank God for His
continued blessings, as well as her parents, Anthony and Miriam Schultz, for their continuous
encouragement and inspiration. She would like to thank her fiancé, James Foster, for his
endless love and support in all things. Finally, she would like to gratefully acknowledge the
entire staff of Nova Law Review, Volume 43, for their dedication and hard work in publishing
this Comment.

Published by NSUWorks, 2019

1

Nova Law Review, Vol. 43, Iss. 2 [2019], Art. 4

178

NOVA LAW REVIEW

I.

[Vol. 43

INTRODUCTION

CRISPR is potentially science and medicine’s greatest invention of
our generation—it could redefine life as we know it today. 1 CRISPR could
be our secret weapon for curing and preventing genetically inherited diseases
such as cancer, Alzheimer’s disease, sickle cell anemia, Amyotrophic Lateral
Sclerosis (“ALS”), and many others. 2 While CRISPR has the potential to
eliminate these diseases, it also might have the potential to cause harm. 3
CRISPR stands for “Clustered Regularly Interspaced Short
Palindromic Repeats of genetic information.” 4 CRISPR Therapeutics
created a powerful gene-editing tool—known as CRISPR—that can be
harnessed to accurately “modify, delete, [and even] correct disease-causing
abnormalities at their genetic [foundation].” 5 Human “DNA is [basically] a
series of instructions” that controls, for example, our height, eye color, and
hair color. 6 These “instructions are written as a series of chemical letters in
our DNA,” and just like letters that make up a textual sentence, there can be
errors or mistakes. 7 An error in the DNA chain can have no effect at all in
one person, but in another, the error of just a single letter can cause a horrific
disease. 8 Specifically, CRISPR embodies the Cas9 enzyme, which acts as a
pair of molecular scissors. 9 The Cas9 enzyme is guided by ribonucleic acid
(“RNA”) which leads the Cas9 enzyme to a specific location where the
enzyme will then slice the DNA. 10 Once a cut has been made in the DNA,
the body’s own natural repair mechanism will trigger the repair of the cut.11

1.
Charles Crutchfield III, CRISPR:
Life-Changing, World-Changing
Science that Will Revolutionize Medicine, MINN. SPOKESMAN-RECORDER (June 1, 2018),
http://www.spokesman-recorder.com/2018/06/01/crispr-life-changing-world-changingscience-that-will-revolutionize-medicine/.
2.
Id.
3.
Id.
THERAPEUTICS:
GENE
EDITING,
4.
CRISPR/Cas9,
CRISPR
http://www.crisprtx.com/gene-editing/crispr-cas9 (last visited May 1, 2019).
5.
Hamza Abdullah, Is CRISPR Dead? A Breakthrough in Genetic
Engineering, MEDIUM (Jan. 9, 2018), http://www.medium.com/search/is-crispr-dead-abreakthrough-in-genetic-engineering-51574d6e6c0d. “Dr. Emmanuelle Charpentier, one of
[CRISPR Therapeutics’] scientific founders, co-invented [the application of] CRISPR/Cas9
[in] gene editing.” CRISPR/cas9, supra note 4.
6.
Crutchfield III, supra note 1.
7.
Id.
8.
Id.
9.
CRISPR/Cas9, supra note 4.
10.
Id.; Therapeutic Approach, CRISPR THERAPEUTICS: GENE EDITING,
http://www.crisprtx.com/gene-editing/therapeutic-approach (last visited May 1, 2019).
11.
CRISPR/Cas9, supra note 4.
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By utilizing the CRISPR-Cas9 technology, it will be possible to delete and
correct hereditary diseases. 12
CRISPR Therapeutics sought approval from the United States Food
and Drug Administration (“FDA”) to begin human genomic editing trials. 13
However, in May of 2018, the FDA denied CRISPR Therapeutics’ request to
move forward with these human trials. 14 The FDA has stated their reasoning
for denying the company’s request involves “certain questions it wants [to
resolve] before it gives the go-ahead for the human CRISPR study.” 15
CRISPR has gone through numerous lab testing experiments
involving non-human trials. 16 These lab results have been promising enough
to suggest that CRISPR is ready to be tested on humans. 17 But until CRISPR
gets the green light to move forward with human trials, “we [cannot] know
for sure whether [CRISPR] will work as expected.” 18 It is important to
realize that these trials would not be the first human trials to ever take
place. 19 In 2016, China was the first country to test CRISPR’s effect on
humans. 20 While it is true that we are exploring uncharted territory and
should certainly proceed with caution, millions of people in the United States
suffer from—and will continue to suffer from—these terrible diseases every
day. 21 The sad truth is that many of those people have exhausted their
options for treatment and CRISPR could be their last hope for survival. 22
Accordingly, this Comment will first examine how the CRISPRCas9 technology works and how it differs from the technology that already
exists. 23 Following this, the many benefits and few legitimate concerns
involving CRISPR will be discussed. 24 In Part III, the analysis will address
12.
Id.; Crutchfield III, supra note 1.
13.
Kristin Houser, The FDA Puts the Brakes on a Major CRISPR Trial in
Humans, FUTURISM: HEALTH & MED. (May 31, 2018), http://www.futurism.com/humancrispr-trial-fda-stops/.
14.
Id.
15.
Id.; see also CRISPR Therapeutics and Vertex Provide Update on FDA
Review of Investigational New Drug Application for CTX001 for the Treatment of Sickle Cell
Disease, CRISPR THERAPEUTICS (May 30, 2018), http://ir.crisprtx.com/news-releases/newsrelease-details/crispr-therapeutics-and-vertex-provide-update-fda-review#.
16.
See Houser, supra note 13.
17.
Id.
18.
Id.
19.
Id.
20.
Id.
21.
Houser, supra note 13; see also Crutchfield III, supra note 1.
22.
See Randi Nord, China Breaks Ground with World’s First CRISPR
Clinical Trials, SOC. UNDERGROUND, http://www.socialunderground.com/2018/04/chinacrispr-gene-editing-cancer/ (last visited May 1, 2019).
23.
See discussion infra Part II.A, II.B.
24.
See discussion infra Part II.C, II.D.
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the central questions of why the current FDA ban was placed on CRISPR
human trials and why CRISPR should get the green light. 25 This section
embarks on a journey into the regulatory framework of the FDA and why
other drugs and devices that have proven to be harmful to consumers—like
tobacco products and chemotherapy—are allowed. 26 Are they regulated by
the FDA? 27 If so, why are we continuing to allow those dangerous and
destructive products on the market, but not CRISPR? 28 Lastly, this
Comment introduces the concept of Big Pharma and addresses the question:
Is Big Pharma involved here? 29
In considering each of these moving parts, one thing stays the
same—CRISPR might offer life-changing cures that could change the future
of mankind. 30 “The catch is we [will not] know for sure until we try.” 31
II.

HOW DOES CRISPR WORK?

In order to understand why the FDA has halted CRISPR human trials
in the United States, we first have to understand how the technology works
and how it affects the human body. 32 After all, the purpose of the FDA is to
protect the general health of the public “by ensuring the safety, efficacy, and
security of human and veterinary drugs, biological products, and medical
devices.” 33
A.

Explanation of Genome Editing

Genome editing is a process by which scientists can genetically
engineer or alter the DNA of an organism—including bacteria, plants,
animals, and even humans. 34 Starting small, the first question becomes:

25.
See discussion infra Part III.B.
26.
See discussion infra Part III.B.2.
27.
See Action on Smoking & Health v. Harris, 655 F.2d 236, 237 (D.C. Cir.
1980); Christian Nordqvist, What You Need to Know About Chemotherapy, MED. NEWS
TODAY, http://www.medicalnewstoday.com/articles/158401.php (last updated Dec. 14, 2017);
What We Do, FDA, http://www.fda.gov/about-fda/what-we-do (last updated Mar. 28, 2018).
28.
See
Effects
of
Tobacco,
TOBACCO
FREE
FLA.,
http://www.tobaccofreeflorida.com/why-should-i-quit/effects-of-tobacco/ (last visited May 1,
2019); Houser, supra note 13; Nordqvist, supra note 27.
29.
See discussion infra Part III.C.
30.
Houser, supra note 13.
31.
Id.
32.
See id.; Crutchfield III, supra note 1.
33.
What We Do, supra note 27.
34.
Genome Editing: What Is Genome Editing?, NAT’L HUM. GENOME RES.
INST. (Aug. 3, 2017), http://www.genome.gov/27569222/genome-editing/.
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What is DNA? 35 DNA stands for deoxyribonucleic acid and consists of four
different bases: Adenine (“A”), Cytosine (“C”), Guanine (“G”), and
Thymine (“T”). 36 DNA exists in the body as a double helix where A must
always pair with T, and, similarly, C must always pair with G. 37 This
chemical pattern is what makes up our hereditary material.38 Moving up to
the next molecule is the gene. 39 One single gene is made up of DNA. 40 One
gene is responsible for one characteristic; for instance, one gene carries the
hereditary information that dictates our eye color. 41 The gene responsible for
our eye color sits on the same part of the DNA chain in every person, but
contains a different make-up of genetic bases. 42 The genome is made up of
all of our genes put together. 43
Just like everything in this world, the human body can make
mistakes. 44 Sometimes a DNA mutation occurs where the nucleotide
sequence that makes up our DNA becomes altered.45 For example, during
the replication process, “the DNA polymerase could read an A instead of a C
and hence add a G instead of a T.” 46
The idea behind genome editing is to locate the DNA mutation or
broken gene, cut out the defect, and repair the DNA chain. 47 Ultimately, by
correcting a harmful mutation, scientists could change the activity of targeted
genes. 48
B.

How is CRISPR Technology Different?

“Scientists have had the knowledge and ability to edit genomes for
many years, but CRISPR technology has brought major improvements to the
35.
DNA (Deoxyribonucleic Acid), MYVMC (July 23, 2008),
http://www.myvmc.com/anatomy/dna-deoxyribonucleic-acid/.
36.
Id.
37.
Id.
38.
Id.
39.
Id.
40.
DNA (Deoxyribonucleic Acid), supra note 35.
41.
Id.
42.
Id.
43.
Id.
44.
Id.
45.
DNA (Deoxyribonucleic Acid), supra note 35.
46.
Id.
47.
Ian Sample, Gene Editing — and What It Really Means to Rewrite the
Code of Life, GUARDIAN, Jan. 15, 2018 at 10. “Scientists liken it to the find and replace
feature used to correct misspellings in documents written on a computer. Instead of fixing
words, gene editing rewrites DNA, the biological code that makes up the instruction manuals
of living organisms.” Id.
48.
Id.
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speed, cost, accuracy, and efficiency of genome editing.” 49 The history of
the different methods utilized to perform genome editing shows the
remarkable progress scientists have been able to make in the field of genetic
engineering. 50
The earliest technique used for gene editing was a process called
homologous recombination. 51 This method involves “generat[ing] and
isolat[ing] DNA fragments bearing genome sequences similar to the portion
of the genome that is to be edited.” 52 Once these fragments are inside the
cell—typically, by injection—“these DNA fragments can then recombine
with the cell’s DNA to replace the targeted portion of the genome.” 53
However, this type of editing is severely limited in that it is not efficient in
most cell types. 54 Because of this, the success rate of homologous
recombination is extremely poor—it “can have as low as a one-in-a-million
probability of successful editing.” 55 Further, this type of editing is known to
have a high rate of error, as the injection of DNA fragments can be inserted
into “unintended part[s] of the genome.” 56
During the 1990s, scientists created zinc-finger nucleases (“ZFNs”),
which are engineered proteins that are programmed to bind to DNA
sequences. 57 Once binding of the protein to the targeted portion of the DNA
sequence occurs, the ZFNs cut the DNA. 58 This process allowed for two
new possibilities: To delete the faulty DNA or replace the faulty DNA with
a new sequence through homologous recombination. 59
More recently, in 2009, scientists created “a new class of proteins
called Transcription Activator-Like Effector Nucleases (“TALENs”).” 60
TALENs are similar to ZFNs in that they bind to specific sequences of
DNA. 61 The only difference between the two is that TALENs are easier to
engineer than ZFNs. 62
49.
Genome Editing: How Does Genome Editing Work?, NAT’L HUM.
GENOME RES. INST. (Aug. 3, 2017), http://www.genome.gov/27569223/how-does-genomeediting-work/.
50.
Id.
51.
Id.
52.
Id.
53.
Id.
54.
Genome Editing: How Does Genome Editing Work?, supra note 49.
55.
Id.
56.
Id.
57.
Id.
58.
Id.
59.
Genome Editing: How Does Genome Editing Work?, supra note 49.
60.
Id.
61.
Id.
62.
Id.
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Now, scientists present the groundbreaking technology we call
CRISPR or more specifically, the CRISPR-Cas9 system. 63 So, how does it
work? 64
With CRISPR, researchers create a short RNA template that
matches a target DNA sequence in the genome. Creating synthetic
RNA sequences is much easier than engineering proteins . . .
required for ZFNs and TALENs. Strands of RNA and DNA can
bind to each other when they have matching sequences. The RNA
portion of the CRISPR, called a guide RNA, directs Cas9 enzyme
to the targeted DNA sequence. Cas9 cuts the genome at this
location to make the edit. CRISPR can make deletions in the
genome and/or be engineered to insert new DNA sequences. 65

C.

Benefits of CRISPR

CRISPR, unlike its predecessors, offers a vast array of improvements
to the genome editing world. 66 “One group of scientists found that CRISPR
is six times more efficient than ZFNs or TALENs in creating targeted
mutations to the genome.” 67 Of CRISPR’s many benefits, a few of the most
noteworthy include the elimination of genetic diseases, cutting down on
major health care costs, high rate of precision and accuracy, and an infinite
supply of organ donors. 68
1.

Elimination of Genetic Diseases

It is no secret that perhaps the most obvious benefit of CRISPR
would be the fact that it has the ability to literally wipe out deadly genetic
diseases. 69
“There are over 600 diseases—like cancer, sickle cell,
Alzheimer’s, Huntington’s, ALS, hemophilia, and many others—that are the
63.
Id.; Sample, supra note 47.
64.
Sample, supra note 47; Genome Editing: How Genome Editing Work?,
supra note 49.
65.
Genome Editing: How Does Genome Editing Work?, supra note 49.
66.
Id.; see also Crutchfield III, supra note 1.
67.
Genome Editing: How Does Genome Editing Work?, supra note 49.
68.
See Pam Belluck, Designer Babies Still Seem Unlikely, N.Y. TIMES, Aug.
5, 2017, at A14; Crutchfield III, supra note 1; Cara MacDonald, CRISPR Could Cure Genetic
Diseases,
DAILY
UTAH
CHRON.
(Apr.
10,
2018),
http://www.dailyutahchronicle.com/2018/04/10/crispr-could-cure-genetic-disease/;
Thom
Patterson, Unproven Medical Technique Could Save Countless Lives, Billions of Dollars,
CNN: HEALTH (Oct. 30, 2015, 7:28 PM), http://www.cnn.com/2015/10/30/health/pioneerscrispr-dna-genome-editing/index.html.
69.
See Sample, supra note 47.
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result of defective DNA [and] CRISPR has the potential to prevent and/or
cure them all.” 70 For example, “5.7 million Americans are living with
Alzheimer’s. [And] [b]y 2050, this number is projected to rise to nearly 14
million.” 71 Stated another way, someone is diagnosed with Alzheimer’s
disease in the United States every sixty-five seconds. 72 That is just one of
the diseases that could be eliminated through the use of CRISPR. 73 Imagine
how many United States citizens could benefit from this ground-breaking
technology—the number could easily be in the millions. 74
Not only would CRISPR wipe out the disease from the suffering
individual, but it would also have the ability to stop the disease from being
inherited by future generations. 75 In addition to being able to modify
somatic cells—non-reproductive cells in the body—it would also be possible
to alter germline cells—egg/sperm cells—producing permanent changes
which will be passed down to all future generations.76 For instance, “sicklecell anemia is an autosomal recessive disease, which means that an affected
individual has inherited a defective hemoglobin gene from both parents, so
every one of his or her sets of chromosomes carries [the] defective gene.” 77
It is with scientific certainty then that all offspring of the two parents will be
plagued with the disease. 78 Repair of the germline would rid that family’s
DNA of sickle-cell anemia for good. 79
It is of the utmost importance that scientists use precaution with
germline editing, “but if we [do not] take the first small step—learning how
to modify embryos precisely and reproducibly and implanting them—[we
will] never reach the goal of ridding families of hideous genetic diseases.” 80
2.

Cutting Down on Health Care Expenses

Not only can CRISPR have an effect on individuals and their
families, but the entire nation—meaning even those not suffering from a
70.
Crutchfield III, supra note 1.
71.
Alzheimer’s and Dementia Facts and Figures, ALZHEIMER’S ASS’N: FACTS
& FIGURES, http://www.alz.org/alzheimers-dementia/facts-figures (last visited May 1, 2019).
72.
Id.
73.
Crutchfield III, supra note 1.
74.
See id.
75.
Sample, supra note 47.
THERAPY
NET,
76.
Types
of
Gene
Therapy,
GENE
http://www.genetherapynet.com/types-of-gene-therapy (last visited May 1, 2019).
77.
Henry I. Miller, Modification of Embryos Will Someday Treat Hideous
REV.:
CULTURE
(Feb.
2,
2016,
7:34
PM),
Diseases,
NAT’L
http://www.nationalreview.com/2016/02/embryo-gene-modification-disease-treatment/.
78.
Id.
79.
See id.
80.
Id.
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genetic disease—could reap the benefits CRISPR has to offer. 81 It is not
surprising that the United States has become famous for its outrageous overspending on health care. 82 Once again, using Alzheimer’s disease as an
example, “[i]n 2018, Alzheimer’s and other dementias . . . cost the nation
$277 billion [and] by 2050, these costs could rise as high as $1.1 trillion.” 83
The math here is simple—if we eliminate the disease, we eliminate the costs
associated with that disease. 84
3.

High Rate of Precision and Accuracy

One of the obvious concerns with using new technology on humans
is whether the technology is going to be safe and actually function the way it
was intended to function. 85 CRISPR has been said to be the Microsoft Word
of the genetic editing world. 86
“‘Genome editing is a little bit like text editing’ . . . . ‘You place a
cursor where you want it and make local changes in the text [you have]
written. We can go in and place our cursor and make a break at one site in
the DNA—exactly where we want it.’” 87

81.
Sample, supra note 47.
82.
Yoni Blumberg, Here’s the Real Reason Health Care Costs So Much
More in the U.S., CNBC (Mar. 22, 2018, 11:37 AM), http://www.cnbc.com/2018/03/22/thereal-reason-medical-care-costs-so-much-more-in-the-us.html.

Id.

The [United States] spent 17.8 percent of its GDP on health care in 2016.
Meanwhile, the average spending of [eleven] high-income countries assessed in a
new report published in the Journal of the American Medical Association—Canada,
Germany, Australia, the [United Kingdom], Japan, Sweden, France, the
Netherlands, Switzerland, Denmark, and the [United States]—was only 11.5
percent.
Per capita, the [United States] spent $9,403. [That is] nearly double
what the others spent.
This finding offers a new explanation as to why America’s spending is
so excessive. According to researchers at the Harvard Chan School, what sets the
[United States] apart may be inflated prices across the board.
In the [United States], they point out, drugs are more expensive.
Doctors get paid more. Hospital services and diagnostic tests cost more. And a lot
more money goes to planning, regulating, and managing medical services at the
administrative level.

83.
Alzheimer’s and Dementia Facts and Figures, supra note 71.
84.
See id.; Crutchfield III, supra note 1.
85.
See Nord, supra note 22.
86.
MacDonald, supra note 68. “It would hypothetically scan the document,
highlight errors, and then correct them.” Id.
87.
Id.
CRISPR uses a natural mechanism in bacteria that functions like a
primitive immune system. It allows scientists to break parts of DNA on
predetermined points so that they can cut areas of DNA with mutations or viruses
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As with any new scientific technology, CRISPR has been tested on
mice and other animals before human testing and the results were nothing
short of astounding. 88 Scientists have treated mosquitos to disable them from
transmitting diseases, such as malaria, and have even treated mice and
monkeys who were once blind, but through CRISPR, are now able to see. 89
Further “[i]n 2017, testing was done to see if the CRISPR-Cas9 gene-editing
method could be used to eliminate [human immunodeficiency virus (“HIV”)]
in infected rodents.” 90 After just one treatment, “all traces of infection
[disappeared] from the mouse’s organs and tissue.” 91
Of course, even though CRISPR is praised for its huge
improvements in accuracy and precision, it is not completely error free.92
One of the main worries is that CRISPR may mutate or edit “unintended
parts of the genome.” 93 However, Dr. Gaetan Burgio noted that “these
unintended mutation[s] are likely to have preexisted prior to the injection of
[the] CRISPR system.” 94
4.

Forget the Shortage of Organ Donors

“Currently in the [United States], an average of [twenty-two] people
die each day waiting for organ transplants because of donor shortages . . . .” 95
But with CRISPR, this is yet another statistic that could change drastically. 96
Instead of twenty-two people dying per day while awaiting an organ for
transplant, imagine if that number were zero.97

Id.

and then edit it. When CRISPR senses a virus invading, it can attack and cut up its
DNA.

88.
See Crutchfield III, supra note 1.
89.
Id.
90.
Alexandra Perry, The Billion-Dollar Industry I Found on YouTube,
ENERGY & CAP. (Jan. 25, 2018, 7:00 PM), http://www.energyandcapital.com/articles/thebillion-dollar-industry-i-found-on-youtube.
91.
Id.
92.
Teodora Zareva, CRISPR May Cause Hundreds of Unintended Mutations
(June
4,
2017),
into
the
Genome,
New
Study
Finds,
BIG THINK
http://www.bigthink.com/design-for-good/new-study-finds-that-crispr-may-cause-hundredsof-unintended-mutations-into-the-genome.
93.
Id.
94.
Id. (quoting Paul Knoepfler, Journal Club Review of New CRISPR “Lots
(May
31,
2017),
of
Off-Target
Activity”
Mouse
Paper,
NICHE
http://www.ipscell.com/2017/05/journal-club-review-of-new-crispr-lots-of-off-target-activitymouse-paper/).
95.
Patterson, supra note 68.
96.
Id.
97.
See id.
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Researchers are now looking to pigs as the newest type of organ
donor. 98 They may not look like us but “their organs and ours are very much
alike.” 99 Specifically, the heart, liver, and kidneys have proven to function
similarly to that of humans and are roughly the same size. 100 A doctor in
Massachusetts has opined that pig organs are a real potential replacement for
almost all human internal organs. 101 “Theoretically, CRISPR-Cas9 could
manipulate the pig genes so human bodies [would not] reject them
[ultimately resulting in] no shortage of available donor organs.” 102
D.

Legitimate Concerns

With such advanced technology, there are inevitably going to be
concerns. 103 While there are legitimate concerns and risks associated with
CRISPR, there are logical ways to address them. 104 After all, sometimes
“[t]he biggest risk is not taking any risk [at all].” 105 The key is to take
intelligent risks. 106
1.

Freewheeling Biohackers

One of the concerns being voiced is that because CRISPR is easier
and cheaper to use than ZFNs or TALENs, it creates room for biohackers. 107
Biohackers are those who are not trained or educated in the field of science,
but who believe, nonetheless, that they can use highly advanced
98.
Pigs May Be Future Organ Donors, ABC NEWS (Aug. 23, 2001),
http://www.abcnews.go.com/WNT/story?id=130708&page=1.
99.
Id.
100.
Id.; Patterson, supra note 68.
101.
Pigs May Be Future Organ Donors, supra note 98. “‘The heart is very
similar, the kidneys are very similar, their function is very similar,’ says Dr. David Sachs of
Massachusetts General Hospital in Boston. ‘So it really is a potential donor for almost all of
the internal organs.’” Id.
102.
Patterson, supra note 68.
103.
See MacDonald, supra note 68.
104.
Id.
105.
Salim Ismail, 3 Ways Companies Can Encourage Smart Risk Taking,
GROWTH
STRATEGIES
(Oct.
16,
2014),
ENTREPRENEUR:
http://www.entrepreneur.com/article/238543.
106.
Id. Overall, “we need to figure out how to balance the risks and potential
rewards of gene editing . . . a meticulous, professional scientist with freewheeling biohackers .
. . practical applications with wild theories; best case scenarios like ending malaria with
catastrophic prophesies of thirty-foot wolves.” Last Week Tonight with John Oliver: Gene
Editing (HBO television broadcast July 1, 2018).
107.
See Carmen Russo, John Oliver Thinks We Need to Stop Freaking Out
CULTURE
(July
2,
2018,
1:44
PM),
About
Gene
Editing,
SLATE:
http://slate.com/culture/2018/07/last-week-tonights-john-oliver-on-gene-editing.html.
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technology. 108 CRISPR is so affordable that biohackers could begin
collecting the supplies needed to operate the CRISPR gene editing
technology and start selling these kits for large-scale public access. 109 In
fact, it is already happening. 110 One of these freewheeling biohackers, Josiah
Zayner, sells do-it-yourself CRISPR kits out of his garage in the state of
California. 111 Mr. Zayner has compared the use of this gene editing
technology to downloading an app. 112 Mr. Zayner then asks the following
hypothetical question: “Why [cannot] people use this technology without
necessarily completely knowing how it works?” 113 While most can easily
see the obvious problem with this convoluted line of thinking, there will
always be those who are metaphorically blind to the magnitude of the effects
that can come from reckless self-experimentation. 114
2.

Designer Babies

Another popular concern is that more and more people will begin to
use this technology to create designer babies. 115 “But there are good reasons
to think that these fears are closer to science fiction than they are to
science.” 116 Although it is possible to alter simple traits with CRISPR,
parents have had “the ability to select their child’s sex, eye color, hair color,
and skin complexion with preimplantation genetic diagnosis” for years; this
is nothing new. 117

note 106.

108.

Id.; see also Last Week Tonight with John Oliver: Gene Editing, supra

109.
Russo, supra note 107; see also Last Week Tonight with John Oliver:
Gene Editing, supra note 106.
110.
Russo, supra note 107; see also Last Week Tonight with John Oliver:
Gene Editing, supra note 106.
111.
Russo, supra note 107; see also Last Week Tonight with John Oliver:
Gene Editing, supra note 106.
112.
Russo, supra note 107; see also Last Week Tonight with John Oliver:
Gene Editing, supra note 106.
113.
Last Week Tonight with John Oliver: Gene Editing, supra note 106. Mr.
Zayner went on to further say, “I want to live in a world where people get drunk and instead
of giving themselves tattoos, they’re like ‘I’m drunk, I’m going to CRISPR myself.’” Id.
Although a ludicrous and quite frankly scary statement, this should not inhibit us from moving
forward with technology that could save the lives of so many. See id.
114.
See id.
115.
Bailey Kirkpatrick, Cut Out the Hype: Gene Editing with CRISPR and the
Truth About Superhuman Designer Babies, WHATISEPIGENETICS.COM (Feb. 28, 2017),
http://www.whatisepigenetics.com/gene-editing-crispr-cas9-designer-babies/; see also Russo,
supra note 107; Last Week Tonight with John Oliver: Gene Editing, supra note 106.
116.
Belluck, supra note 68.
117.
Kirkpatrick, supra note 115.
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The main fear then becomes whether we can control more “complex
traits such as intelligence, personality, or temperament.” 118 For example,
could parents custom-order a baby with Usain Bolt’s speed or Beyonce’s
vocal range? 119 The answer is simply no because the diseases which
CRISPR was made to cure are defects appearing on a single gene or
sometimes “an easily identifiable number of genes.” 120 Conversely, a
person’s intelligence, personality, or other special skill arises from an
incalculable number of genes. 121 Not only are traits such as personality and
temperament controlled by a myriad of genes, but in addition, these traits are
molded by our environments and by personal experiences. 122 Thus, scientists
are nowhere near being able to alter and predetermine such complex traits.123
3.

What Constitutes a Genetic Problem That Needs Fixing?

Lastly, there is another more complicated issue that is causing
growing concern. 124 CRISPR’s whole platform centers around the fact that,
with this new technology, we can fix and even eliminate genetic problems
that cause diseases. 125 But “who decides what constitutes a genetic problem
that needs to be fixed?” 126 For example, is deafness considered a disease? 127
Or dwarfism? 128 There are some people who might think so, but many with

118.
119.
120.

Id.

Id.
Belluck, supra note 68.
Id.

Here is what researchers did: [R]epair a single gene mutation on a
single gene, a defect known to cause—by its lonesome—a serious, sometimes fatal,
heart disease.
Here is what science is highly unlikely to be able to do: [G]enetically
predestine a child’s Ivy League acceptance letter, front-load a kid with Stephen
Colbert’s one-liners, or bake Beyonce’s vocal range into a baby.

121.
See id. “Even with an apparently straightforward physical characteristic
like height, genetic manipulation would be a tall order. Some scientists estimate height is
influenced by as many as 93,000 genetic variations.” Id.
122.
Kirkpatrick, supra note 115.
123.
See Belluck, supra note 68.
124.
See Russo, supra note 107; Last Week Tonight with John Oliver: Gene
Editing, supra note 106.
125.
See CRISPR/Cas9, supra note 4.
126.
Last Week Tonight with John Oliver: Gene Editing, supra note 106.
127.
Russo, supra note 107; see also Last Week Tonight with John Oliver:
Gene Editing, supra note 106.
128.
Russo, supra note 107; see also Last Week Tonight with John Oliver:
Gene Editing, supra note 106.
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such conditions do not. 129 This is a subjective concept which creates a vast
gray area. 130
Consider the following factual scenario: A young boy named Martin
is an albino, meaning “his genes do not give the right instructions for his
body’s production of pigment, the dye that colors the skin, eyes, and hair.” 131
As a result, Martin was born with extremely pale skin and “is at high risk of
sunburn and skin cancer” when exposed to sunlight. 132 In addition, his light
eyes cause poor vision and harsh light can hurt his eyes. 133 Consider also the
fact that Martin’s mother is worried about him because he is bullied at school
by other children in his class for his skin color and hair color. 134 If genetic
treatment is made readily available to Martin to produce the average amount
of pigmentation in his skin, should he have the treatment? 135 “In other words
[is] . . . being albino . . . a medical problem that needs fixing? Or . . . is [it]
more along the lines of a nose job or face-lift—something nice, but not
necessary?” 136 And what about the choice Martin’s mother may have to
make? 137 “If she loves Martin the way he is, how does she explain a decision
to have him treated? But if he is unhappy with the way he is, how does she
explain a decision not to treat him?” 138 These are difficult questions because
there is technically no correct answer as everyone may have a different
opinion on the issue. 139
III.

THE CURRENT FDA BAN ON CRISPR HUMAN TRIALS IN THE
UNITED STATES

In December 2017, CRISPR Therapeutics officially announced their
merger with a biotech company called Vertex. 140 Through their partnership,
the two companies produced the CTX001—a special version of CRISPR—to
treat sickle-cell patients. 141 As with all forms of genetic treatment, CRISPR
129.
See Russo, supra note 107; Last Week Tonight with John Oliver: Gene
Editing, supra note 106.
130.
See Russo, supra note 107; Last Week Tonight with John Oliver: Gene
Editing, supra note 106.
131.
CATHERINE BAKER, YOUR GENES, YOUR CHOICES: EXPLORING THE ISSUES
RAISED BY GENETIC RESEARCH 12 (1999).
132.
Id.
133.
Id.
134.
Id. at 9.
135.
See id. at 12.
136.
BAKER, supra note 131, at 12.
137.
Id.
138.
Id.
139.
See id. at 13.
140.
Houser, supra note 13.
141.
Id.
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and Vertex collectively sought approval from the FDA to move forward with
human trials with consenting adult volunteers. 142 However, after review, the
FDA denied the request, “placing a clinical hold on the application.” 143
According to a recent press release held by CRISPR Therapeutics, the FDA
has expressed certain questions with regard to CRISPR technology and will
not permit the company to proceed with testing on humans. 144
A.

Has CRISPR Been Tested in Other Countries?

China has been conducting human trials for several years now—
making China the first country in the world to conduct human trials with
CRISPR technology. 145 Dr. Shixiu Wu, head of the Hangzhou Cancer
Hospital located in China, is perhaps one of the doctors most heavily
associated with the use of CRISPR. 146 Dr. Wu treats many patients with
advanced esophageal cancer—one of the most common forms of cancer in
China. 147 Typically, Dr. Wu treats his patients in the ways that most of us
are probably familiar with, such as chemotherapy and radiation treatments. 148
In one case, Dr. Wu treated a fifty-three year old man suffering from
advanced esophageal cancer through many rounds of chemotherapy and
radiation, but the cancer just kept spreading. 149 Upon the suggestion of
CRISPR, Dr. Wu’s patient expressed interest in this form of experimental
treatment. 150 Dr. Wu then explained that the process—called T-cell
infusion—would involve “using cells from [the patient’s] own immune
system, known as T-cells, after they ha[d] been taken out of his body and
genetically altered in a lab by the gene-editing tool called CRISPR.” 151 The
cells are modified “so that they zero in on and attack the cancer cells once
[they are] infused back into each patient”—basically instructing the immune

142.
Id.; What Is Gene Therapy?, FDA: VACCINES, BLOOD & BIOLOGICS (July
25, 2018), http://www.fda.gov/vaccines-blood-biologics/cellular-gene-therapy-products/whatgene-therapy.
143.
Houser, supra note 13.
144.
Id.
145.
Kristen V. Brown, China Has Already Gene-Edited 86 People with
CRISPR, GIZMODO: GENETICS (Jan. 22, 2018, 1:00 PM), http://www.gizmodo.com/china-hasalready-gene-edited-86-people-with-crispr-1822297524; Nord, supra note 22.
146.
See Rob Stein, Doctors in China Lead Race to Treat Cancer by Editing
Genes, NPR (Feb. 21, 2018, 5:00 AM), http://www.npr.org/sections/healthshots/2018/02/21/585336506/doctors-in-china-lead-race-to-treat-cancer-by-editing-genes.
147.
Id.; Nord, supra note 22.
148.
Nord, supra note 22.
149.
Stein, supra note 146.
150.
See id.
151.
Id.
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system to attack the malignant cancerous cells.152 After preparation of the Tcells was complete, the patient was intravenously infused with “millions of
genetically modified immune system cells” which flowed into his veins for
about an hour. 153 After his very first infusion, the patient reported feeling a
bit weak initially, but feeling better and feeling very stable soon after. 154
Although Dr. Wu is still treating this patient, Dr. Wu remarked that another
one of his patients has been doing well after almost a full year of CRISPR
treatments. 155 Although one of Dr. Wu’s patients decided to discontinue
with CRISPR treatments after experiencing a high fever, “[t]he rest appear to
be stable or in partial remission [after] . . . undergoing monthly
treatments.” 156 Dr. Wu reports that a total of nine patients have died in the
study, “but Wu says that was from their cancer, not the [CRISPR]
treatment.” 157
“So far, [twenty-one] patients have participated in the trials [and]
[t]he efficiency was about [forty] percent.” 158 At first glance, forty percent
does not seem like a very high success rate, but the fact is that forty percent
is significantly better than zero percent.159
B.

Why the FDA Should Allow Human Trials in the United States

Although it is important to have a cautious gatekeeper in place,
“[t]he FDA is commonly viewed as a roadblock.” 160 “Patients are looking
for answers. Biotech is looking for big bucks. Both oppose regulation.” 161
While it is no doubt imperative to ensure medical technology is not harming
individuals, the question boils down to whether competent and informed
adults should be able to subject themselves to risk. 162

152.
Id.
153.
Id.
154.
Stein, supra note 146.
155.
Id.
156.
Id.
157.
Id.
158.
Nord, supra note 22.
159.
See id.
160.
Megan Molteni, China Used CRISPR to Fight Cancer in a Real, Live
Human, WIRED: SCI. (Nov. 18, 2016, 2:00 PM), http://www.wired.com/2016/11/china-usedcrispr-fight-cancer-real-live-human/.
161.
Id.
162.
Id.
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Many of Those with Genetic Diseases Are Out of Options

“Clinical research attempts to address a relatively straightforward,
and extremely important challenge: [H]ow do we determine whether one
medical invention is better than another, whether it offers greater clinical
benefit and/or poses fewer risks?” 163 CRISPR is now at the stage where it
requires testing with real, live humans. 164 Human testing of any kind poses
some kind of risk to the patient “no matter how many laboratory and animal
tests have preceded them.” 165 Herein lies the ethical dilemma: When does it
become permissible to expose living, breathing human beings to a risk of
harm to further medical research? 166
With medical devices like CRISPR, scientists and medical providers
“should be permitted to conduct research and expose subjects to risks
provided they obtain [the] subjects’ ‘free, voluntary, and undeceived consent
and participation.’” 167 Yet, the FDA does not regard the notion of informed
consent as a sufficient basis for human testing. 168 Are the FDA’s limitations
“justified, or are they inappropriate infringements on the free actions of
competent individuals” who have otherwise run out of options? 169
Looking at the twenty-one patients who have undergone CRISPR
treatments in China, it is easy to see why the country allowed such treatment
and why patients were voluntarily subjecting themselves to serve as guinea
pigs of the new technology. 170 Every single one of those patients was
suffering from an advanced stage of cancer and had already tried surgery,
chemotherapy, and radiation to no avail. 171 After exhausting all other
methods of killing the cancer cells, these patients would ultimately be told
there is nothing further doctors can do. 172 If not for CRISPR, these patients
would be out of options and would live each day knowing it could be their
last. 173
The bottom line is that most of the ethical concerns that arise from
exposure of humans to CRISPR are shattered when the patient, if of age and
163.
David Wendler, The Ethics of Clinical Research, STAN. ENCYCLOPEDIA
PHIL. (Feb. 27, 2017), http://plato.stanford.edu/entries/clinical-research/.
164.
See Houser, supra note 13.
165.
Wendler, supra note 163.
166.
Id.
167.
Id. (quoting JOHN STUART MILL, ON LIBERTY 16 (Currin V. Shields ed.,
The Bobbs-Merrill Co. 1956) (1859)).
168.
See id.; What We Do, supra note 27.
169.
Wendler, supra note 163; What We Do, supra note 27.
170.
See Nord, supra note 22.
171.
Id.
172.
Id.
173.
See id.
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standard mental competence, cannot be helped by any other form of
treatment. 174
2.

But What About These Products?
a.

Big Tobacco

Imagine if every product with harmful qualities were regulated in the
same way as CRISPR. 175 The United States is proceeding with the utmost
caution in allowing CRISPR human trials, yet we allow products like
cigarettes to be sold to the general public every day. 176 “Causing more than
480,000 deaths each year in the United States, smoking is the leading
preventable cause of death in the United States.” 177 Smoking damages
almost every organ in the human body and contributes to serious health
issues such as stroke, heart disease, and, of course, lung cancer. 178 Not only
is smoking responsible for causing lung cancer, but it can cause just about
any type of cancer imaginable. 179 “If nobody smoked, one in every three
cancer deaths in the United States would not occur.” 180
Perhaps even more troubling is the lengthy and frightening list of
chemicals found in cigarettes. 181 “[O]f the [ninety-three] known harmful . . .
chemicals [found] in cigarettes,” a few particularly troublesome chemicals
include: Nicotine, cadmium, lead, acetaldehyde, benzene, ammonia, and
carbon monoxide. 182 These chemicals—many of which are known to be
deadly—are contained in each and every cigarette. 183 This is what our
governmental regulatory agencies are allowing to be ingested by United
States citizens every day. 184

174.
See id.
175.
See Nord, supra note 22.
176.
See Houser, supra note 13; Effects of Tobacco, supra note 28.
177.
Effects of Tobacco, supra note 28.
178.
Id.
179.
Id. “Such areas include (but are not limited to): [T]he bladder,
bloodstream, cervix, colon, rectum, esophagus, kidney, ureter, larynx, liver, oropharynx,
pancreas, stomach, trachea, bronchus, and lung.” Id.
180.
Id.
181.
Chemicals in Cigarettes: From Plant to Product to Puff, FDA,
http://www.fda.gov/tobacco-products/products-ingredients-components/chemicals-cigarettesplant-product-puff (last visited May 1, 2019).
182.
Id.
183.
USFoodandDrugAdmin, Chemicals in Every Puff of Cigarette Smoke —
(Feb.
13,
2017),
Combustion
Stage,
YOUTUBE
http://www.youtube.com/watch?v=EXdxl0yH904.
184.
See What We Do, supra note 27.
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One of the common reservations with regard to tobacco litigation is:
Why should individuals be suing tobacco companies when they are
knowingly and willfully smoking cigarettes that have proven to be directly
linked to causing lung cancer—that was their choice, right? 185 In this day
and age, when all of this data has been made available to the public, that is
certainly a valid question. 186 And it is this very same logic that should be
used when we evaluate tools like CRISPR. 187 With genetic counseling, and
all that is known thus far about CRISPR, individuals can make informed
decisions about whether they wish to proceed with the new form of treatment
or keep exploring other options. 188
One of the reasons tobacco companies are able to continuously
market and sell their deadly product is because of how the FDA’s regulatory
framework is structured. 189 Interestingly, the intent of the manufacturer
determines whether the FDA will have jurisdiction over a given product. 190
Where a manufacturer intends for a product to affect the human body in
structure or function, it will be labeled a drug or device that is subject to
FDA regulation. 191 For example, CRISPR Therapeutics claims their product
can eliminate genetic diseases through the mutation or alteration of genes—
making it subject to FDA authority. 192 The FDA proclaims that their goal is
to protect the health and safety of the public by guaranteeing that drugs and
devices are safe and effective for their intended use. 193 While it is true that
tobacco companies generally do not make therapeutic claims regarding their
products, cigarettes certainly have an effect on the structure and function of
the human body—a largely negative one at that.194 Nicotine should certainly

185.
Robert L. Rabin, A Sociolegal History of the Tobacco Tort Litigation, 44
STAN. L. REV. 853, 871 (1992); Effects of Tobacco, supra note 28.
186.
See Effects of Tobacco, supra note 28. However, that is not a valid
question for plaintiffs who qualify for class certification and have standing in regard to the
Engle progeny cases. Engle v. Liggett Grp., 945 So. 2d 1246, 1267 (Fla. 2006).
187.
See Genome Editing: What Is Genome Editing?, supra note 34.
188.
See id.; Crutchfield III, supra note 1; Houser, supra note 13.
189.
See Action on Smoking & Health v. Harris, 655 F.2d 236, 238–39 (D.C.
Cir. 1980); Daniel F. Hardin, Blowing Electronic Smoke: Electronic Cigarettes, Regulation,
and Protecting the Public Health, 2011 U. ILL. J.L. TECH. & POL’Y 433, 439.
190.
Hardin, supra note 189, at 439; see also 21 U.S.C. § 321 (2012).
191.
Hardin, supra note 189, at 439; see also 21 U.S.C. § 321.
192.
CRISPR/Cas9, supra note 4; see also FDA v. Brown & Williamson
Tobacco Corp., 529 U.S. 120, 126 (2000), superseded by statute, Family Smoking Prevention
and Tobacco Control Act, Pub. L. No. 111-31, 123 Stat. 1776 (2009) (quoting 21 U.S.C. §
321(g)–(h)).
193.
What We Do, supra note 27.
194.
Brown & Williamson Tobacco Corp., 529 U.S. at 155; Effects of Tobacco,
supra note 28.
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qualify as a drug since it has been proven time and time again to have potent,
addictive qualities. 195
In 1996, however, the FDA did attempt to regulate cigarettes on the
grounds that cigarettes are both a drug and a device because they deliver
exact and controlled amounts of nicotine to the body to sustain addiction. 196
In the famous case, FDA v. Brown and Williamson Tobacco Corp., 197 the
Supreme Court of the United States found that the FDA was precluded from
regulating tobacco products. 198 The Supreme Court held that if the FDA
were to have jurisdiction over tobacco products, they would be banned from
the market as “no measures the agency could take would make tobacco
products safe for human use.” 199 “The Court reasoned Congress favored
informing consumers about adverse health risks of tobacco use over harming
the nation’s economy through an outright ban of tobacco.” 200
In applying this to CRISPR, there is no doubt that CRISPR makes a
therapeutic claim and, thus, constitutes a medical device subject to FDA
jurisdiction. 201 But what kind of message does it send to allow billions of
cigarettes to be sold every day with the knowledge that the FDA would ban
them in a heartbeat if they were in the driver’s seat of tobacco’s
marketability? 202 Perhaps the answer is that the blood of the United States
runs green with greed. 203 If there were as big a desire to help one another as

195.
The Top 5 Most Addictive Drugs in the World, RECOVERY FIRST,
http://www.recoveryfirst.org/drug-abuse/most-addictive-drugs/ (last updated June 6, 2016).
Ranking in at number three, “[n]icotine is considered one of the most addictive substances in
the world.” Id.

Id.

Part of the reason nicotine is so addictive is that this stimulant decreases
appetite, boosts mood, and increases heart rate, blood pressure, and alertness.
However, it has a very short life span in the bloodstream, with users typically
feeling cravings for nicotine after [two to three] hours. This craving often includes
psychological symptoms like anxiety [or] depression, along with headaches or
restlessness.

196.
Brown & Williamson Tobacco Corp., 529 U.S. at 127.
197.
529 U.S. 120 (2000).
198.
Id. at 133.
199.
Hardin, supra note 189, at 440 (citing Brown & Williamson Tobacco
Corp., 529 U.S. at 135–36) (discussing the FDA’s failed attempt to regulate traditional
tobacco).
200.
Id. at 440–41; see also Brown & Williamson Tobacco Corp., 529 U.S. at
138–39.
201.
See 21 U.S.C. § 321(g)–(h); Crutchfield III, supra note 1; What We Do,
supra note 27.
202.
See Brown & Williamson Tobacco Corp., 529 U.S. at 135–36; Hardin,
supra note 189, at 440–41.
203.
See Brown & Williamson Tobacco Corp., 529 U.S. at 138–39; Hardin,
supra note 189, at 440–41.
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Hardin, supra note 189, at 440 (citing Brown & Williamson Tobacco
Corp., 529 U.S. at 135–36) (discussing the FDA’s failed attempt to regulate traditional
tobacco).
200.
Id. at 440–41; see also Brown & Williamson Tobacco Corp., 529 U.S. at
138–39.
201.
See 21 U.S.C. § 321(g)–(h); Crutchfield III, supra note 1; What We Do,
supra note 27.
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See Brown & Williamson Tobacco Corp., 529 U.S. at 135–36; Hardin,
supra note 189, at 440–41.
203.
See Brown & Williamson Tobacco Corp., 529 U.S. at 138–39; Hardin,
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there is to make a profit, maybe CRISPR would already be doing away with
genetic diseases. 204
b.

Even the Widely Used Chemotherapy

Another harmful product used on a daily basis is chemotherapy—
conceivably the most commonly used and well-known cancer treatment
available. 205 “[C]hemotherapy refers to the drugs that prevent cancer cells
from dividing and growing. It does this by killing the dividing cells.” 206 In
essence, the combination of drugs used in chemotherapy will:
[I]mpair mitosis, or prevent cell division . . . ;
[T]arget the cancer cells’ food source, which consists of the
enzymes and hormones they need to grow;
[T]rigger the suicide of cancer cells, known medically as
apoptosis; [and]
[S]top the growth of new blood vessels that supply a tumor in
order to starve it. 207

Given this wide array of functions, it is not surprising that
chemotherapy comes with a long list of side effects and reaching the
remission stage is not always guaranteed. 208 Most are aware of the common
and almost inevitable side effects of chemotherapy—nausea, vomiting,
alopecia (hair loss), fatigue, and anemia. 209
But what about the effects of chemotherapy that are not so
common? 210 “Back in September 2004, the Centers for Disease Control and
Prevention (“CDC”) and the National Institute for Occupational Safety &
Health (“NIOSH”) . . . warned that working with chemotherapy drugs and
other common pharmaceuticals can be a serious danger to your health.” 211
Ironically, “one of the effects of chemotherapy is that it actually [causes]
204.
See Brown & Williamson Tobacco Corp., 529 U.S. at 139; Crutchfield III,
supra note 1.
205.
See Nordqvist, supra note 27.
206.
Id.
207.
Id.
208.
See id.
209.
Id.
210.
See Ty Bollinger, The Truth About Chemotherapy — Toxic Poison or
ABOUT
CANCER
(May
5,
2015),
Cancer
Cure?,
TRUTH
http://www.thetruthaboutcancer.com/truth-about-chemotherapy/.
211.
Id.
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cancer!” 212 Further, numerous chemical specialists are of the opinion that in
reality, chemotherapy does much more harm than it does good. 213 “The truth
is that chemo is toxic, carcinogenic (causes cancer), destroys erythrocytes
(red blood cells), devastates the immune system, and destroys vital
organs.” 214
Chemotherapy, as we know, can have catastrophic side effects; in
comparison, CRISPR’s are minimal. 215 Looking at the human trials
performed in China, Dr. Wu has said “the only side effects have been mostly
minor—an occasional fever or rash.” 216 Just like chemotherapy has proven,
the mere fact that a drug produces side effects does not automatically bar it
from FDA approval. 217 “[E]very new therapy has some potential [for] side
effects—[the key is], we need to be aware of what they are.” 218
C.

Is This Big Pharma at Play?

Imagine if you had the power to change the world—to rid it of
disease, to save millions, to ease someone else’s pain and suffering—all
while earning a profit. 219 If you were to start up a pharmaceutical
conglomerate, this is likely what your end goal would look like. 220 Initially,
you plan to use your company for good and you truly desire to help the
212.
Id.
213.
Id. “Dr. Alan C. Nixon, past president of the American Chemical Society
writes, ‘As a chemist trained to interpret data, it is incomprehensible to me that physicians can
ignore the clear evidence that chemotherapy does much, much more harm than good.’” Id.
214.
Bollinger, supra note 210. “The serious toxic effects of chemotherapy
have long been ignored by virtually everyone in medicine and the federal government.
Chemotherapy drugs have always been assumed to be safe just because [they are] used to treat
cancer. This is an outright lie.” Id.
215.
See id.; Nord, supra note 22. Dr. Wu stated that “although [he has] only
used the technology on a small number of people, it appears much safer than traditional
chemotherapy.” Nord, supra note 22.
216.
Stein, supra note 146.
217.
See Bollinger, supra note 210; Nordqvist, supra note 27.
218.
Zareva, supra note 92.
Chemotherapy is an invasive treatment that can have severe adverse effects. This is
because the drugs often target not only cancerous cells but also healthy cells. The
adverse effects can be worrying, but given early, chemotherapy can in some cases
achieve a complete cure, making the side effects bearable for many patients. It is
important that patients know what to expect before starting treatment.

Nordqvist, supra note 27. Sound familiar?* This is the exact premise that should be used
when discussing the administration of CRISPR to human patients. See id.
219.
BIG PHARMA, http://www.bigpharmagame.com (last visited May 1, 2019).
Video game inventors even made an online game called Big Pharma with the slogan,
“Marketing and Malpractice is the brand new expansion for Big Pharma. . . . [You have]
created your wonder drug, now it is time to sell, sell, sell.” Id.
220.
See id.
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human race. 221 But the uncomfortable truth is that “illness is good for
business.” 222 This is the world of Big Pharma. 223
Big Pharma is often used to describe “massive pharmaceutical
companies that make literally billions of dollars every year to keep
Americans regularly supplied with a medicine cabinet’s worth of pills.” 224
So how do these pharmaceutical companies have an influence on
CRISPR? 225
Due to their extremely high profit margins, Big Pharma has some
pretty deep pockets and “[w]ith those pockets comes a strong hand of
political and legislative influence.” 226 Even though the FDA has been
instituting massive fines, Big Pharma companies are significant contributors
to the FDA’s budget, thus “leading to concerns of conflicts of interest and
outright bribery.” 227 For these reasons, the pharmaceutical industry is now
being referred to as America’s new mafia. 228
Big Pharma has raised a lot of eyebrows for the money it
can throw at doctors and legislators, but perhaps the most serious
effect it has had on American healthcare is the epidemic of the
overprescription of powerfully addictive drugs . . . The United
States makes up only [five] percent of the world’s population but
consumes [eighty] percent of the painkillers in the world. 229

Pharmaceutical companies, theoretically, are “meant to write
themselves out of the equation. True success—a world without disease—
would also mean a world without drugs and a world without
pharmaceuticals.” 230 But when pharmaceutical companies are successful in

DESERT
2016).

221.
See id.
222.
Id.
223.
BIG PHARMA, supra note 219.
224.
Who Are the Players in the Pharmaceutical Industry (Big Pharma)?,
HOPE, http://www.deserthopetreatment.com/big-pharma/ (last updated Nov. 28,

225.
See id.
226.
Id.
227.
Id.
228.
Id.
229.
Who Are the Players in the Pharmaceutical Industry (Big Pharma)?,
supra note 223. “A 2011 survey conducted by the Kaiser Family Foundation revealed that
Americans aged [nineteen through sixty-four] were prescribed an average of 11.9
prescriptions, and Americans [sixty-five] and up received an average of [twenty-eight]
prescriptions.” Id.
230.
Elizabeth Balboa, Curing Disease Is Bad for Business: How Do Big
Pharma Companies Continue Their Growth?, BENZINGA (Feb. 14, 2017, 8:55 AM),
http://www.benzinga.com/general/biotech/17/02/9017199/curing-disease-is-bad-for-businesshow-do-big-pharma-companies-continu.
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actually curing patients, they no longer have a purpose, “and the market
responds to that lost purpose by withdrawing investments.” 231 Adam
Feuerstein, a national biotech columnist, made a Twitter post stating:
“Perhaps the awful, brutally honest lesson here is: Curing disease is great for
patients but sucks for business.” 232 This is the premise behind Big Pharma—
“[s]uccess is not always profitable in the pharmaceutical industry, and [it is]
this perspective [that has] fueled numerous conspiracy theories . . . about
drug companies intentionally missing their marks.” 233
Although CRISPR does not have the ability to cure every disease, it
could potentially cure some of health care’s most expensive treatments—
HIV, cancers, and Alzheimer’s. 234 As mentioned previously, Alzheimer’s
disease—along with other forms of dementia—“will cost the nation $277
billion [and] by 2050, these costs could rise as high as $1.1 trillion.” 235
“[That is] why Bloomberg is calling CRISPR-Cas9 ‘the discovery of the
century’ and Science magazine is calling it ‘the breakthrough of the
year.’” 236
On the one hand, CRISPR could shatter the conspiracy theory behind
Big Pharma. 237 Pharmaceutical companies may not be the biggest advocates
of CRISPR since CRISPR could have the potential to disrupt their trilliondollar industry; curing so many diseases might just be bad for business. 238
231.
Id.
232.
Adam Feuerstein (@adamfeuerstein), TWITTER (Feb. 7, 2017, 6:18 PM),
http://twitter.com/adamfeuerstein/status/829152296764395520; Adam Feuerstein, STAT,
http://statnews.com/staff/adam-feuerstein/ (last visited May 1, 2019). One stock market
trader, Dennis Dick, said “[t]he bottom line here is: [D]on’t make your drugs so effective . . . .
[That is] a sad world we live in when capitalism is going to punish a stock because their drugs
are too effective.” Balboa, supra note 230.
233.
Id. “Some wonder if pharmaceuticals announce just enough progress to
draw in funds while maintaining a safe distance from cure-driven obsolescence.” Id.
234.
Perry, supra note 90.
235.
Alzheimer’s and Dementia Facts and Figures, supra note 71.
In the United States, an average of $173 billion is spent every year on cancer
research. Heart disease treatment costs another $200 million annually. Then there
is diabetes, which is on the rise and costs Americans $245 billion annually. Those
are some big numbers, and they [are not] even the worst. Alzheimer’s, one of the
scariest diseases to any aging human—which is all of us—costs Americans $259
billion a year! When you do the math, that means just four diseases are raking up a
$1 trillion medical bill. And [that is] just the big boys. Imagine the costs that come
with genetic diseases that appear at birth—diseases that parents will pay for
throughout their child’s adolescence. Then when that child becomes an adult, they
will inherit the costs of a disease they never wanted and [could not] fight. But with
CRISPR-Cas9, that could end. In our current war against disease, [it is] Big
Pharma that rakes in the dough.

Perry, supra note 90.
236.
Id.
237.
See id.; Balboa, supra note 230.
238.
See Perry, supra note 90.
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On the other hand, CRISPR might open up a brand new realm of income that
Big Pharma might want in on. 239 The still young industry surrounding the
CRISPR-Cas9 system “could form the foundation of a billion-dollar geneediting industry.” 240
IV.

CONCLUSION

As demonstrated throughout this Comment, CRISPR has massive
medicinal potential. 241 CRISPR has the ability to rid the world of deadly
genetic diseases, make real changes in the cost of healthcare in the United
States, make stellar improvements to the accuracy and precision of genetic
editing, and even eliminate the growing need for organ donors. 242 Although
the legitimate concerns expressed should not be taken lightly, many of those
concerns “are closer to science fiction than they are to science.” 243
Further, there is a lot to learn from the country that has been testing
CRISPR on humans for years now. 244 This is not to say that the FDA should
not keep doing its job; however, when looking at the drugs and devices that
are allowed on the market today, the fact that CRISPR is not allowed leaves
room for serious questions. 245 Is the FDA really the ethical gatekeeper it
presents itself to be? 246 Or is it actually persuaded by profit? 247 With
tobacco products and chemotherapy in heavy use in this country, and Big
Pharma’s influence, the latter seems to be the winning answer. 248
“Hopefully, CRISPR Therapeutics and Vertex are able to answer the
FDA’s questions in a way that promotes confidence in the treatment.” 249
While it is important to keep in mind that we are exploring uncharted
territory and certainly should proceed with caution, the truth is that millions
of people throughout the United States, as well as the rest of the world, suffer
from diseases that could be cured by CRISPR technology. 250
239.
See id.
240.
Id.
241.
Crutchfield III, supra note 1.
242.
Id.; MacDonald, supra note 68; Patterson, supra note 68.
243.
Belluck, supra note 68.
244.
See Molteni, supra note 160; Stein, supra note 146.
245.
See Hardin, supra note 189, at 439, 449; Molteni, supra note 160; Stein,
supra note 146.
246.
See Molteni, supra note 160.
247.
See Who Are the Players in the Pharmaceutical Industry (Big Pharma)?,
supra note 224.
248.
See id.; Balboa, supra note 230; Bollinger, supra note 210; Effects of
Tobacco, supra note 28.
249.
Houser, supra note 13.
250.
Id.; see also Crutchfield III, supra note 1.
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One thing is clear—CRISPR could change the world. 251 The only
question that remains is: When will the United States give it the chance? 252

251.
Crutchfield III, supra note 1; see also Houser, supra note 13.
252.
See Houser, supra note 13. Just one month after the submission of this
Comment, the United States made the decision to sponsor the first CRISPR human trial.
Catherine Offord, US Companies Launch CRISPR Clinical Trial, THESCIENTIST (Sept. 3,
2018), http://www.the-scientist.com/news-opinion/us-companies-launch-crispr-clinical-trial64746. “Although the study itself is to be carried out in a hospital in Germany, it marks the
first clinical trial of CRISPR genome-editing technology to be sponsored by [United States]
companies, Boston based Vertex Pharmaceuticals and CRISPR Therapeutics, a Swiss
biopharmaceutical [company] with labs in Cambridge, Massachusetts.” Id. These companies
will “jointly launch[] a trial of an experimental CRISPR-Cas9 therapy for the blood disorder
ß-thalassemia, according to [an] announcement posted Friday, August 31, [2018].” Id.
CRISPR Therapeutics [Chief Executive Officer], Samantha Kulkarni, stated, “Just three years
ago we were talking about CRISPR-based treatment as a sci-fi fantasy . . . But here we are.”
Id.
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